首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
Methods for treating irritable bowel syndrome (IBS)
摘要
The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.
申请公布号
AU2010292043(A1)
申请公布日期
2012.03.29
申请号
AU20100292043
申请日期
2010.09.13
申请人
SALIX PHARMACEUTICALS, LTD.
发明人
FORBES, WILLIAM;JOHNSON, LORIN;BORTEY, ENOCH
分类号
A61K39/395
主分类号
A61K39/395
代理机构
代理人
主权项
地址
您可能感兴趣的专利
System, Machine, and Computer-Readable Storage Medium for Forming an Enhanced Seismic Trace Using a Virtual Seismic Array
Integration of a Polynucleotide Encoding a Polypeptide that Catalyzes Pyruvate to Acetolactate Conversion
RICE CULTIVAR CL172
REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS
Method to Produce Virus in Cultured Cells
BIOREACTOR USING MACROALGAE
PHOTONIC WINE PROCESSOR
PROCESSES FOR RECOVERING HYDROCARBONS FROM A DRAG STREAM FROM A SLURRY HYDROCRACKER
LOW DEGREE OF SUBSTITUTION SODIUM CARBOXYMETHYLCELLULOSE FOR SOIL STABILIZER AND WATER RETARDANT FILM
RESIN FORMED BODY HAVING SURFACE THAT EXHIBITS EXCELLENT WATER-SLIDING PROPERTY
ADHESIVE COMPOSITIONS CONTAINING FUNCTIONALIZED ETHYLENE/ALPHA-OLEFIN INTERPOLYMERS AND ROSIN-BASED TACKIFIERS
VISCOSITY MODIFIER, AND EMULSION RESIN COMPOSITION OR AQUEOUS COATING COMPOSITION EACH CONTAINING SAME
WATER-BASED INK FOR INKJET RECORDING
HOSE RUBBER COMPOSITION AND HOSE
POLYAMIDE RESIN COMPOSITION HAVING HIGH MELT POINT AND BEING EXCELLENT IN ANTI-VIBRATION PROPERTY UPON WATER ABSORPTION
ACTIVE ESTER RESIN CONTAINING PHOSPHORUS ATOM, EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF, PREPREG, CIRCUIT BOARD, AND BUILD-UP FILM
POLYOL FORMULATIONS CONTAINING FILLERS AND POLYURETHANES PRODUCED THEREFROM
AROMATIC HYDROCARBON FORMALDEHYDE RESIN, MODIFIED AROMATIC HYDROCARBON FORMALDEHYDE RESIN, AND EPOXY RESIN, AND METHOD FOR PRODUCING THESE
Synthesis of Nanostructured Carboxycelluloses from Non-Wood Cellulose
ANTI-CXCL9, ANTI-CXCL10, ANTI-CXCL11, ANTI-CXCL13, ANTI-CXCR3 AND ANTI-CXCR5 AGENTS FOR INHIBITION OF INFLAMMATION